跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ENVARSUS PA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ENVARSUS PA
Authorized
STANDARD
ENVARSUS PA
Endo Operations Ltd.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bdd2128a350f9d87
Company
Endo Operations Ltd.
Type
Standard
Approval Details
Approval Id
bdd2128a350f9d87
Drug Approval Canada Name
ENVARSUS PA
Product Name
ENVARSUS PA
Status
Marketed
Status Date
2019-04-17
Original Market Date
2019-04-17
Din
02485885
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
90:28.28.92
Atc Original
L04AD02 TACROLIMUS
Atc Name
l 04 ad 02
Aig Number
0127857002
Company Name
Endo Operations Ltd.
Company Address
1st Floor, Minerva House, Simmonscourt Road, Ballsbridge, Dublin, Ireland, D04 H9P8
Active Ingredients
TACROLIMUS
1 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bdd2128a350f9d87
Type
Standard
Back to Health Canada Approvals